Médecine

Paramédical

Autres domaines


S'abonner

Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations - 24/08/11

Doi : 10.1016/j.jaad.2003.12.003 
Jashin J Wu, MD a, David B Huang, MD, MPH b, Katie R Pang, MD a, Stephen K Tyring, MD, PhD, MBA , c
a Center for Clinical Studies, Houston, Texas, USA 
b Department of Internal Medicine, Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA 
c Departments of Dermatology, Microbiology-Immunology, and Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA 

*Reprint requests: Stephen K. Tyring, MD, PhD, MBA, Professor of Dermatology, University of Texas Health Science Center, Houston, 2060 Space Park Dr, Ste 200, Houston, TX 77058, USA.

Abstract

Although the development of antimicrobial drugs has advanced rapidly in the past several years, such agents act against only certain groups of microbes and are associated with increasing rates of resistance. These limitations of treatment force physicians to continue to rely on prevention, which is more effective and cost-effective than therapy. From the use of the smallpox vaccine by Jenner in the 1700s to the current concerns about biologic warfare, the technology for vaccine development has seen numerous advances. The currently available vaccines for viral illnesses include Dryvax for smallpox; the combination measles, mumps, and rubella vaccine; inactivated vaccine for hepatitis A; plasma-derived vaccine for hepatitis B; and the live attenuated Oka strain vaccine for varicella zoster. Vaccines available against bacterial illnesses include those for anthrax, Haemophilus influenzae, and Neisseria meningitidis. Currently in development for both prophylactic and therapeutic purposes are vaccines for HIV, herpes simplex virus, and human papillomavirus. Other vaccines being investigated for prevention are those for cytomegalovirus, respiratory syncytial virus, parainfluenza virus, hepatitis C, and dengue fever, among many others. Fungal and protozoan diseases are also subjects of vaccine research. Among immunoglobulins approved for prophylactic and therapeutic use are those against cytomegalovirus, hepatitis A and B, measles, rabies, and tetanus. With this progress, it is hoped that effective vaccines soon will be developed for many more infectious diseases with cutaneous manifestations.

Learning objective

At the completion of this learning activity, participants should be familiar with the current and experimental vaccines and immunotherapies for infectious diseases with cutaneous manifestations.

Le texte complet de cet article est disponible en PDF.

Abbreviations : AVA, CDC, CRM197, DTaP, DTP, HbOC, HBsAg, Hib, HPV, HSV, IVIG, LACK, MMR, OspA, OspC, PA, PGA, PRP, PRP-D, PRP-OMP, rOspA, SSPE, VIG, VLP


Plan


 Funding sources: None.
Disclosure: Dr Tyring has conducted research on vaccines for vesicular stomatitis virus, herpes simplex virus, human papillomaviruses, and HIV with grants from Merck, Chiron, GlaxoSmithKline, MedImmune, and VaxGen to the University of Texas Medical Branch and the Center for Clinical Studies.


© 2004  American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 50 - N° 4

P. 495-528 - avril 2004 Retour au numéro
Article précédent Article précédent
  • Manuscript submission online
| Article suivant Article suivant
  • CME examination : Identification No. 804-104 Instructions for Category I CME credit appear in the front advertising section. See last page of Contents for page number

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

;

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.